Original paper

SGLT-2 Inhibitors and Cardiovascular Risk

Volume: 71, Issue: 22, Pages: 2497 - 2506
Published: Jun 1, 2018
Abstract
Prior studies found patients treated with sodium-glucose co-transporter-2 inhibitors (SGLT-2i) had lower rates of death and heart failure (HF). Whether the benefits of SGLT-2i vary based upon the presence of cardiovascular disease (CVD) is unknown.This study sought to determine the association between initiation of SGLT-2i therapy and HF or death in patients with and without CVD.The CVD-REAL (Comparative Effectiveness of Cardiovascular Outcomes...
Paper Details
Title
SGLT-2 Inhibitors and Cardiovascular Risk
Published Date
Jun 1, 2018
Volume
71
Issue
22
Pages
2497 - 2506
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.